Originally published In Press as doi:10.1074/jbc.M000995200 on April 14, 2000
J. Biol. Chem., Vol. 275, Issue 27, 20903-20910, July 7, 2000
Calcineurin Controls the Transcription of
Na+/Ca2+ Exchanger Isoforms in Developing
Cerebellar Neurons*
Lei
Li
,
Danilo
Guerini
§, and
Ernesto
Carafoli
¶
From the
Institute of Biochemistry, Swiss Federal
Institute of Technology, 8092 Zürich, Switzerland, the
§ Laboratory of Metabolic and Cardiovascular Diseases,
Novartis AG, 4002 Basle, Switzerland, and the ¶ Department of
Biochemistry, University of Padova, 35121 Padova, Italy
Received for publication, February 7, 2000, and in revised form, April 11, 2000
 |
ABSTRACT |
The Na+/Ca2+
exchanger (NCX) and the plasma membrane Ca2+-ATPase export
Ca2+ from the cytosol to the extracellular space. Three NCX
genes (NCX1, NCX2, and NCX3),
encoding proteins with very similar properties, are expressed at
different levels in tissues. Essentially, no information is available
on the mechanisms that regulate their expression. Specific antibodies
have been prepared and used to explore the expression of NCX1 and NCX2
in rat cerebellum. The expression of NCX2 became strongly up-regulated
during development, whereas comparatively minor effects were seen for
NCX1. This was also observed in cultured granule cells induced to
mature in physiological concentrations of potassium. By contrast,
higher K+ concentrations, which induce partial
depolarization of the plasma membrane and promote the influx of
Ca2+, caused the complete disappearance of NCX2. Reverse
transcription-polymerase chain reaction analysis showed that the
process occurred at the transcriptional level and depended on the
activation of the Ca2+ calmodulin-dependent
protein phosphatase, calcineurin. The NCX1 and
NCX3 genes were also affected by the depolarizing
treatment: the transcription of the latter became up-regulated, and the
pattern of expression of the splice variants of the former changed. The effects on the NCX1 and NCX3 genes were
calcineurin-independent.
 |
INTRODUCTION |
Hormonal and electrical stimuli promote the penetration of
Ca2+ into cells to activate cellular responses.
Ca2+ must then be continuously extruded, because its
uncontrolled increase in the cytosol would lead to cell death. Two
systems, a pump (1) and a Na+/Ca2+ exchanger
(2), eject Ca2+. The latter system, which is particularly
active in heart and neurons, uses the Na+ gradient
generated by the Na+/K+-ATPase to remove
Ca2+ from the cytosol; under normal conditions 3 Na+ ions are exchanged for 1 Ca2+.
The cDNA of exchanger type 1 (NCX1)1 has been cloned from
mammalian (3-8), amphibian (9), and invertebrate (10, 11) tissues. A
comparison of the sequences shows a high level of conservation. The
mature NCX1 is a glycosylated protein (12) of 970 amino acids, the
first 32 of which are post-translationally cleaved off (13-15). The
original membrane topography model based on hydropathy analysis
predicted 11 transmembrane domains, separated by small loops and by a
large intracellular loop (>500 amino acids) between transmembrane
domains 5 and 6. A more recent model based on cysteine accessibility
studies has revised the number of predicted transmembrane domains down
to 9 (16), eliminating 2 from the C-terminal half of the exchanger.
Although the large intracellular loop is not strictly necessary for the
activity of the exchanger, it contains important regulatory elements
(17-19). Its C-terminal portion is subjected to alternative splicing
(20), which also occurs at the 5'-untranslated region of the gene
(21-23). Numerous splicing variants have been described for NCX1. The
amount of the major variant present in neurons (the AD isoform) is
altered by protein kinase A (24). Although
-adrenergic stimulation
led to the increase of NCX1 mRNA in cultured cardiac myocytes (25),
glucocorticoids and protein kinase A down-regulated it in vascular
smooth muscle cells. Protein kinase C had the same effect in
endothelial cells (26, 27). Changes in the expression of the
NCX1 gene have also been observed during cardiac development
(28) and pressure overload (29).
Two additional exchanger genes encoding proteins with high homology to
NCX1 have also been cloned: NCX2 (30) and NCX3
(31). Whereas NCX1 is expressed at high levels in heart, and
is thus normally referred to as the "cardiac form" of the protein
even if also present in other tissues, significant amounts of
NCX2 and NCX3 mRNAs have only been detected
by Northern blots in brain and skeletal muscles. However, minor amounts
were detected also in other tissues using more sensitive RT-PCR
methods. Some splice variants have been detected for NCX3
but none so far for NCX2.
Although the exchanger proteins have not been satisfactorily purified,
comparisons of the biochemical properties of the NCX1, NCX2, and NCX3
exchangers have been made on membrane preparations and on
overexpressing cells. Because no significant differences were detected
(32), the rationale for the existence of three separate NCX
genes is obscure. Brain cells, in particular neurons, contain
large amounts of all three basic NCX isoforms and of their splice
variants and are thus good models for study. In this research, their
expression was investigated during the development of rat cerebellum
and of cultured cerebellar granule neurons. The work has shown that
Ca2+ and calcineurin are critical to the expression of the
exchanger genes, supporting the idea that one of the major differences
among the NCX genes is the regulation of their transcription.
 |
EXPERIMENTAL PROCEDURES |
Materials
The pTM3 vector and the vvT7 virus were gifts from Dr. B. Moss
(National Institutes of Health, Bethesda, MD). Cyclosporin A and FK506
were a kind gift of Dr. Mauro Zurini (Novartis, Basle, Switzerland).
Dulbecco's modified Eagle medium (DMEM or DME/F12) and other tissue
culture supplements were from Sigma or Life Technologies. Poly-L-lysine and 3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide were from
Sigma. 45Ca2+, [
-32P]dCTP, and
[14C]ATP were from Amersham Pharmacia Biotech.
Nitrocellulose filters for Western blotting and Nytran for Northern
blotting were from Schleicher & Schuell. Nitro blue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate and goat anti-rabbit
alkaline phosphatase conjugate were from Promega (Madison, WI).
Chemiluminescence substrates CDP-starTM and NitroblockII
were from Tropix (Madison, WI). Oligonucleotides were purchased from
MGW-Biotech (Ebersberg, Germany). Ampli-Taq Gold polymerase
was from Perkin-Elmer.
Methods
Cell Cultures--
HeLa cells were cultured in Dulbecco's
modified Eagle medium supplemented with 5-10% fetal calf serum and 50 µg/ml gentamicin in 5.5% CO2 at 37 °C. Transient
expression of NCX1 was achieved by infecting cells with t7 polymerase
containing vaccinia virus at a multiplicity of infection of 20 followed
by transfection of the plasmid DNA (33).
Granule cells were dissociated from the cerebella of 7-day-old Wistar
rats as described (34). They were plated in Dulbecco's modified Eagle
medium (Hepes modification, Sigma) supplemented with heat-inactivated
10% fetal calf serum (Sigma), 100 µg/ml gentamicin, 7 µM
p-aminobenzoic acid, 100 µg/ml pyruvate, and 100 microunits/ml insulin on poly-L-lysine-treated plates at a density of 2-3 × 105 cells/cm2 in the
presence of 5.3 or 25 mM KCl. After 24 h, 10 µM cytosine arabinofuranoside was added to inhibit
mitotic cell growth. Neuronal survival was estimated by measuring the
amount of colored formazan in the cells by the reduction of 3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (35). The
extent of contaminating astrocytes was estimated by immunocytochemistry
using a monoclonal antibody specific for the glial fibrillary acidic
protein (GFAP, Roche Molecular Biochemicals). Immunocytochemistry was
performed as described earlier (36).
Isolation of RNA, RT-PCR, and Northern Blotting--
Total RNA
was prepared from granule cells according to the method of Chomczynski
and Sacchi (37). cDNA was synthesized using a random primer
(First-strand cDNA synthesis kit, Amersham Pharmacia Biotech)
according to the manufacturer's protocol. PCR was performed using the
following oligonucleotides: NCX1-F (rat NCX1, 1760-1782), atgttatcattccctataaaacc; NCX1-R (rat NCX1, 2117-2136),
ctcctctttgctggtcagtg; NCX2-F (rat NCX2; 1453-1472),
ctgcgtgtgggcgatgctc; NCX2-R (rat NCX2; 1965-1983),
gacctcgaggcgacagttc; NCX3-F (rat NCX3, 2534-2555), gacagtagaaggaacagccaag; NCX3-R (rat NCX3; 2808-2828),
tttagggtgttcacccaatac; G3PDH-F (rat G3PDH, 371-391),
ccaaaaggggtcatcatctcc; G3PDH-R (rat G3PDH, 994-1015),
gtaggccatgaggtccaccac; Fos-F (rat fos, 660-680), aagtctgcgttgcagaccgag; Fos-R (rat fos, 1040-1020),
gtctgctgcatagaaggaacc; PMCA4CII (rat PMCA4CII, 3622-3647), gaggaggtgtaacggcagaag.
The conditions for the PCR reactions were as suggested by Perkin-Elmer
for the Taq Gold polymerase. The identity of the
PCR-generated fragments was verified by sequencing. The G3PDH fragment
encompassed cDNA nucleotides 371-1015 (38). RNA was denatured by
formaldehyde and formamide and fractionated on a 1% agarose gel
containing 20 mM MOPS-NaOH, 8 mM sodium
acetate, 1 mM EDTA, pH 7.0, and 6% formaldehyde. After
separation, RNA was transferred to Nytran filters by capillary elution
in 10× SSC buffer, prehybridized, and hybridized in 5× Denhardt's
solution, 5× SSPE, 0.1% SDS, 0.1 mg/ml denatured salmon sperm DNA,
0.2-1 × 106 cpm/ml labeled DNA, and 50% formamide
at 42 °C overnight. Nytran filters were washed in 0.1× SSC, 0.1%
SDS twice at room temperature for 15 min, once at 55 °C for 30 min,
and once at 65 °C for 20 min prior to the exposure to x-ray films or
to PhosphorImager screens.
Western Blotting--
The gel sample buffer contained 6 M urea, 5% SDS, 4% dithiothreitol, 50 mM
Tris-HCl, pH 8.0, and 5 mM EDTA. After electrophoresis, proteins were blotted onto a nitrocellulose sheet (39). The membrane
was blocked at room temperature in Tris-buffered saline (25 mM Tris-HCl, 500 mM NaCl) with 3% gelatin and
then incubated for 60-90 min with exchanger polyclonal antibodies
(diluted 1/500 or as indicated) in TBST (Tris-buffered saline
containing 0.05% Tween 20 and 1% gelatin). After three washes with
TBST, the membrane was incubated with a secondary antibody conjugated
to alkaline phosphatase (Promega) for 1 h followed by washing. The
staining reaction was carried out either with nitro blue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate according to the
ProtoBlot System (Promega) or with chemiluminiscence substrate
CDP-starTM (Tropix) according to the manufacturer's instructions.
Immunoprecipitation--
Granule cells were cultured under
different conditions for 4 days at a density of 2.5 × 106 cells/well in a 6-well plate. The medium was replaced
with methionine-free minimum essential medium supplemented with
[35S]methionine (150 µCi/ml) and incubated overnight.
The cells were rinsed with phosphate-buffered saline, and crude
membrane proteins were prepared. The labeled cells (corresponding to
about 5,000,000 cpm) were solubilized in 10 mM Tris-HCl, pH
8.0, 1 mM EDTA, 0.5% SDS. NET buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.25% gelatin, 0.1%
Nonidet P-40, 1 mM EDTA) was added to dilute SDS to a final concentration of 0.2%. Triton X-100 and sodium deoxycholate were added
to final concentrations of 0.3 and 0.5%, respectively. The mixture was
incubated for 30 min at 4 °C. After centrifugation at 15,000 × g, the supernatant was incubated with the primary antibody
(5 µl of serum) at 4 °C on a rocking plate for at least 1 h.
To recover the immunoprecipitates, protein A-coupled Sepharose CL-4B
(20 µl pre-equilibrated in NET buffer) was added to the mixture and
incubated at 4 °C for at least 30 min under gentle rocking. The
protein A-Sepharose-primary antibody complex was recovered by
centrifugation (1-2 min in a microcentrifuge) and washed four times
with 20 volumes of NET buffer, twice with NPT buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Nonidet P-40), and
once with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl.
The material bound to protein A-Sepharose was released by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample
buffer. The immunoprecipitates were analyzed by SDS-PAGE and exposed to
a PhosphorImager plate or x-ray films.
Membrane Preparations--
Cells were resuspended at a density
of 5-10 × 106 cells/ml in 10 mM
Tris-HCl, pH 8.0, 1 mM EDTA, 5 µg/ml leupeptin, 5 µg/ml aprotinin, 5 µg/ml pepstatin, 75 µg/ml phenylmethylsulfonyl
fluoride, and 1 mM dithiothreitol and subjected to three
cycles of freeze-thaw. The particulate fraction was sedimented at
15,000 × g for 15 min. The resulting protein pellet
was resuspended in 4 mM Tris-HCl, pH 8.0, 10% sucrose and
frozen at
70 °C. Cerebella were dissected from rat brains and
homogenized in 5 mM Tris-HCl, pH 7.5, 320 mM
sucrose, 5 µg/ml each pepstatin, antipain, and leupeptin with a loose
Potter homogenizer. A crude synaptosomal membrane fraction was obtained
by centrifuging the post-nuclear supernatant at 12,000 × g for 10 min at 4 °C. The supernatant was then
centrifuged at 100,000 × g for 1 h at 4 °C.
The material precipitated at 100,000 × g was defined
as the microsomal fraction.
Determination of the Na+/Ca2+ Exchanger
Activity in Granule Cells--
Granule cells (1.25 × 106/well) were plated on poly-lysine-coated, 12-well plates
and cultured in the presence of 25 mM KCl or 25 mM KCl and 100 nM FK506 for 7 days. The cells
were washed twice with 140 mM NaCl, 2 mM
MgCl2, 1 mM ouabain, 25 µM
nystatin, 20 mM MOPS-Tris, pH 7.4, and incubated for 15 min
in the same buffer at 37 °C. After two washes with 140 mM NaCl, 20 mM MOPS-Tris, pH 7.4, 2 mM MgCl2, Ca2+ uptake was initiated
by overlaying the cells with a buffer containing 140 mM
KCl, 50 µM CaCl2
(45Ca2+ 2-4.106 cpm/ml), 1 mM ouabain, 20 mM MOPS-Tris, pH 7.4 (uptake
buffer). Control experiments were carried out by substituting 140 mM NaCl for KCl in the uptake buffer. The reaction was
stopped at different time intervals with a buffer containing 10 mM LaCl3, 100 mM MgCl2, 20 mM MOPS-Tris, pH 7.4. The amount of Ca2+
taken up by the cells was determined after their lysis in 2% SDS, 10 mM Tris-HCl, pH 8.0.
Preparation of Isoform-specific Na+/Ca2+
Exchanger Antibodies--
Portions of the NCX1 (amino acids 566-691
(3)) and the NCX2 (amino acids 486-661 (30)) sequences located in the
large cytosolic loop were chosen to raise isoform-specific antibodies (a portion of the sequence of NCX3 located in this region was also
chosen). The corresponding cDNA fragments were amplified from rat
brain RNA by RT-PCR using the following oligonucleotides: NCX1-F
(1760-1782), atgttatcattccctataaaacc; NCX1-R (2117-2136), ctcctctttgctggtcagtg; NCX2-F (1453-1472), ctgcgtgtgggcgatgctc; NCX2-R
(1965-1983), gacctcgaggcgacagttc. The fragments were cloned into the
expression vector pRSET. The expression of the Histidine-tagged fusion
peptides was performed according to the procedure suggested by
Invitrogen (Leek, The Netherlands). The fusion proteins encompassed 36 amino acid residues deriving from the vector. The NCX1 and NCX2
peptides were purified on a nitrilo-triacetic acid
(Ni2+-NTA) column under denaturing conditions, yielding
highly purified products (>95% according to Coomassie Brilliant
Blue-stained gels). The polypeptides were utilized to immunize rabbits,
using standard procedures (40). The antibodies were affinity-purified
on an antigen-coupled Sepharose column as described earlier (40).
 |
RESULTS |
Antibodies Specific for the Na+/Ca2+
Exchanger Isoforms--
Antibodies specific for the NCX1 and NCX2
isoforms were prepared using peptides encompassing the region subjected
to alternative splicing (Fig.
1A) as epitopes, because this
region shows a low degree of sequence conservation in the three
isoforms: The identity of the peptides was below 44% (Fig.
1B). Fig. 1B also lists a peptide derived from
the main loop of NCX3. It had been planned originally to generate
antibodies specific for NCX3 as well, choosing for this purpose a
domain of low sequence conservation; however, none of the injected
rabbits produced an adequate NCX3 antiserum. The NCX1-specific
antiserum recognized the exchanger in dog cardiac sarcolemma (bands at
about 110, 160, and 70 kDa) or the NCX1 expressed in HeLa cells (Fig.
1C). These three bands are typical for NCX1; the 70-kDa band
is a proteolytic product (33), the 110-kDa band is the full-length
protein, and the 160-kDa band is an internally locked variant of the
exchanger that migrates with abnormal mobility (41). The amount of the
internally locked version of the exchanger varies with the preparation
and cell type and was not visible in overexpressing cells; this may
have been a consequence of a different membrane composition of Hela as
compared with muscle cells. No exchanger-specific bands were recognized
by the NCX2 antiserum in these membranes. The NCX2 affinity-purified
antibodies recognized instead a strong band at 102 kDa, which was the
expected mass of NCX2 in brain membranes. Further experiments showed a very good correlation between the amount of NCX2-specific mRNA and
the 102-kDa immunoreactive band. Blots with the NCX1 and NCX2 peptides
used to immunize the rabbits and with the peptide derived from NCX3
indicated that the reaction of the NCX1 and NCX2 antibodies was
isoform-specific (not shown), i.e. none of them recognized NCX3.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Isoform-specific polyclonal antibodies.
A, membrane model of the exchanger. The original topographic
model of the exchanger, based on hydropathy plots, is shown. As
mentioned in the text, an alternative model based on cysteine
accessibility studies (16) has now also been proposed. Transmembrane
domains are indicated by cylinders and the exons involved in
the alternative splicing (documented for NCX1) by boxes
A-F. The regulatory Ca2+ binding site in the
N-terminal region of the large cytosolic loop is also shown. The
location of the peptides used to generate the antibodies is indicated
by the open (NCX1) and closed
(NCX2) ribbons. B, percent sequence
homology of the peptides of the isoforms used to generated the
antibodies. The homology of a peptide from the sequence of NCX3, which
had also been selected but failed to produce adequate antibodies, is
also shown. C, 30 µg of proteins prepared from bovine
heart sarcolemmal vesicles (lane 1) (57) and 10 µg of
crude membrane proteins of HeLa cells overexpressing NCX1 using the
vaccinia virus expression system (33) (lane 2) were
separated by SDS-PAGE, transferred to nitrocellulose sheets, and
incubated with antibodies against the NCX1 and NCX2 exchangers. The
blot incubated with the NCX1 antibody was developed for 5 min, that
with the NCX2 antibodies for 60 min. The asterisks indicate
bands resulting from unspecific reactions that were observed when the
blots were developed for longer than 60 min. The immunocomplexes were
visualized as described under "Experimental Procedures."
D, 30 µg of membrane proteins (microsomal fraction) from
the cerebella of 21-day-old rats were immunoblotted with antibodies
specific for the NCX1 and NCX2 exchangers. Similar results were
obtained with synaptosomal fractions (not shown). The molecular masses
of protein markers are given on the left.
|
|
Expression of NCX1 and NCX2 during the Development of Cerebellum
and the Maturation of Granule Cells in Vitro--
Analysis of the
cerebellum from developing rats showed that the expression of NCX2
increased markedly during post-natal development, whereas only slight
changes were observed for NCX1 (Fig.
2A). To simplify the study,
experiments were then performed on cultured granule cells. Under
appropriate conditions, these cells survive for a relatively long time,
and their cultures contain more than 95% neurons (Fig. 2B).
In the presence of physiological concentrations of KCl (5.3 mM), the cells matured to full neurons, but their numbers
steadily decreased during the first days of culture, with only a few
surviving after 7 days (Fig. 2B, top). The experiment in
Fig. 2C shows that, in analogy to what was observed in whole cerebellum, the NCX2 protein became strongly up-regulated during the
first days in culture in the 5.3 mM KCl medium. By
contrast, as had been the case for the cerebellum, no evident changes
were observed in the expression of NCX1. The long-term survival of granule cells in culture requires the chronic depolarization of the
plasma membrane by higher concentrations of KCl (Fig. 2B, bottom) (34, 42). Recent studies have shown that under these conditions the expression of some of the Ca2+ transporting
proteins, specifically, plasma membrane Ca2+ pumps and
plasma membrane and internal Ca2+ channels, underwent
significant changes (43-45). As preliminarily indicated in a recent
review (46), the Na+/Ca2+ exchanger was also
affected by these conditions. Fig. 2D shows that a drastic reduction of
the NCX2 protein occurred; After 5 days in 25 mM KCl,
hardly any of the protein could be detected (Fig. 2D),
whereas only marginal effects were observed for NCX1. The expression of
NCX2 was very sensitive to the depolarizing treatment; an increase of
KCl in the medium from 5.3 to 15 mM was sufficient to
almost completely down-regulate it (Fig. 2E).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of NCX1 and NCX2 during the
development of cerebellum and during the maturation of cultured granule
cells. A, NCX1 and NCX2 proteins in the cerebellum.
Crude membrane proteins (microsomal fraction) were prepared from 3-, 7-, 12-, and 21-day-old rats. 25-30 µg of membrane proteins were
separated by SDS-PAGE (8%), blotted to nitrocellulose sheets, and
incubated with antibodies specific for the NCX1 and NCX2 exchangers.
The molecular masses of protein markers are given in the
center of the panel (arrows).
B, maturation and survival of cultured granule cells: phase
contrast images of granule cells cultured for 2, 3, 5, and 7 days.
Changes characteristic of neuronal development are observed after a few
days in cells cultured either in low (5.3 mM KCl) or high
(25 mM KCl) concentrations of KCl. However, survival
improved markedly when cells were cultured under mild depolarizing
conditions (25 mM KCl). C, crude membrane
proteins (25-30 µg) from granule cells cultured at physiological KCl
(5.3 mM) for different times were separated by SDS-PAGE
(8%) and probed with isoform-specific antibodies. D and
E, down-regulation of the expression of NXC2 by
depolarization. D, crude membrane proteins (25-30 µg)
from granule cells cultured for 5 days in the presence of 5.3 or 25 mM KCl were separated by SDS-PAGE and analyzed with
isoform-specific antibodies. E, granule cells cultured for 5 days in the presence of either 5.3, 15, or 25 mM KCl. Crude
membrane proteins (25-30 µg) were separated by SDS-PAGE and analyzed
with the NCX2-specific antibodies.
|
|
Effects of Depolarization on the Transcription of NCX Isoforms in
Cerebellum and Cultured Granule Cells--
RT-PCR with
isoform-specific oligonucleotides was used to detect NCX
transcripts, in particular their alternatively spliced variants (20,
47). In the case of NCX1, sequencing demonstrated that seven
different splice isoforms were present after 3 days of culturing in
non-depolarizing KCl concentrations (Fig.
3A, lane M). In the case of
NCX1, up to four different PCR fragments were visible in
gels (Fig. 3, lane 1). In both the cerebellum and the cells,
the AD spliced variant was predominant (Fig. 3A, compare
lanes 1-4 with lanes 5 and 6). In
cells cultured in 25 mM KCl for 3 to 5 days, the amounts of
the AD and ADF isoforms increased, and this increase was accompanied by
the disappearance of the larger variants (Fig. 3A).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of depolarization on the transcription
of NCX isoforms. A, NCX1 isoforms. RT-PCR on RNA
isolated from granule cells and rat cerebellum with NCX1
isoform-specific oligonucleotides. RNA was prepared from granule cells
after 3 (lanes 1 and 2) or 5 (lanes 3 and 4) days of culture in the presence of 5.3 (lanes
1 and 3) or 25 (lanes 2 and 4)
mM KCl. RNA was also prepared from the cerebella of 7- and
21-day-old rats (lanes 5 and 6, respectively). RNA was
reverse-transcribed, amplified with primers specific for NCX1, and
separated on 8% PAGE. PCR products obtained from granule cells were
subcloned in pGEM-T vectors; 3-4 independent clones of the different
fragments were sequenced. A mixture containing 6 of the 7 fragments
found in granule cells, separated on 8% PAGE, is shown in lane
M (fragment ADF was not included). DNA was visualized by staining
with ethidium bromide. B, transcripts of the NCX2
(B1) and NCX3 (B2) isoforms in granule cells. RNA
was isolated from cells cultured for 3 (lanes 1 and
2) or 5 (lanes 3 and 4) days in the
presence of either 5.3 (lanes 1 and 3) or 25 (lanes 2 and 4) mM KCl,
reverse-transcribed, and amplified in parallel with oligonucleotides
specific for NCX2 (B1) and NCX3 (B2). The PCR
products were separated on 8% PAGE and stained with ethidium bromide.
C, Northern blotting of NCX2. 15 µg of total RNA from
granule cells cultured for 3 or 5 days in the presence of 5.3 or 25 mM KCl were separated on a formaldehyde-agarose gel,
transferred to a nylon membrane, and incubated with
32P-labeled NCX2 or G3PDH DNA. The blots for G3PDH were
exposed for 48 h and those for NCX2 for 6 days.
|
|
At variance with NCX1, the RT-PCR experiment revealed a
large, depolarization-dependent down-regulation of the
NCX2 transcript (Fig. 3B1), which was confirmed
by Northern blotting (Fig. 3C). In contrast, the NCX3
transcript became up-regulated by the depolarizing conditions
(Fig. 3B2).
The Down-regulation of NCX2 Is Dependent on
Ca2+--
The depolarization of granule cells by 25 mM KCl causes a sustained, albeit limited, increase of
intracellular Ca2+ (45). This is because of the increased
potential across the neuronal plasma membrane (from
70 to
40 mV)
and the consequent opening of voltage-dependent
Ca2+ channels. After 5 days in culture, the increase was
about 3-fold (from about 50 to about 150 nM). Two
experiments were carried out to verify whether the depolarization
effects on NCX2 expression were the direct results of the increased
Ca2+ influx. Cells were incubated in the presence of the
L-type channel agonist BayK 8644 (Fig.
4A), or the influx of
Ca2+ was increased by manipulating the extracellular
calcium concentration (Fig. 4B). The agonist failed to
influence the level of NCX2 protein at the physiological concentration
of KCl (5.3 mM) but reproducibly reduced its level when the
KCl concentration in the culturing medium was raised to 10 mM (Fig. 4A). Under these conditions, no effect
on the level of NCX1 protein was observed. Similarly, increasing the
extracellular concentration of Ca2+ had a dramatic effect
on the expression of NCX2 even at non-depolarizing KCl concentrations.
When the extracellular Ca2+ concentration was raised to 3.6 mM, the level of NCX2 protein decreased very markedly, even
in 5.3 M KCl, and disappeared almost completely at 5 mM Ca2+ (Fig. 4B). Again, the effect
was specific for NCX2, i.e. it was not observed with
NCX1.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
Ca2+-dependent
down-regulation of NCX2. A, Western blotting analysis
of NCX1 and NCX2 in granule cells cultured in the presence of the
L-type calcium channel agonist BayK 8644 (1 µM). Cells
were cultured for 5 days in the presence (+) or absence ( ) of the
agonist and 5.3, 10, and 15 mM KCl, respectively. 20 µg
of crude membrane proteins from granule cells were separated by
SDS-PAGE, transferred to nitrocellulose sheets, and subjected to
Western blotting with isoform-specific antibodies. B,
influence of extracellular Ca2+ on the expression of NCX2
and NCX1. Granule cells were cultured for 5 days in either low or high
KCl in the presence of the extracellular calcium
(exCa2) at the concentrations indicated. 20 µg of
crude membrane proteins from granule cells were separated on 8%
SDS-PAGE, transferred to nitrocellulose sheets, and subjected to
Western blotting with affinity-purified polyclonal antibodies against
NCX1 and NCX2. The positions of the NCX1 and NCX2 bands are indicated
by the arrows.
|
|
The Expression of NCX2 Is Controlled by Calcineurin--
Prior to
investigating the role of calcineurin, attempts were made to establish
whether the Ca2+ effects on NCX2 expression could be
mediated by calmodulin kinases. Unfortunately, the most widely used
inhibitors of these enzymes, among them KN-92 and KN-93, proved highly
toxic to granule cells, i.e. the great majority of the cells
died after a few hours of incubation with these inhibitors. The time of
survival was too short to reliably explore a possible function of
calmodulin kinases.
To investigate the possible involvement of the
Ca2+-calmodulin-stimulated phosphatase, calcineurin
experiments were carried out with the immunosuppressant drugs FK506 and
cyclosporin, which bind to their respective immunophilins to become
efficient inhibitors of calcineurin. The specificity of the effect of
FK506 can be verified using rapamycin, an immunosuppressant that binds
to the FK506-binding immunophilin, FKBP, but fails to inhibit
calcineurin. However, high amounts of rapamycin compete with FK506 for
binding to FKBP, therefore blocking its inhibitory effects. FK506 and cyclosporin A prevented the depolarization-mediated down-regulation of
NCX2 (Fig. 5A); rapamycin did
not, but it blocked the effect of FK506 when present at 2000-fold in
excess of the latter. The expression of InsP3R1
(inositol trisphosphate receptor isoform 1), which has recently been
shown to be controlled by calcineurin (44), was used as a control in
Fig. 5A; in contrast to NCX2, it was up-regulated by the
depolarization (Fig. 5A). Immunoprecipitation experiments of
the NCX2 protein from granule cells incubated for 5 days with FK506
using the NCX2-specific antiserum further confirmed that the
down-regulation of NCX2 was reversed by calcineurin inhibitors (Fig.
5B). When cells were cultured under depolarizing conditions, neither RT-PCR nor Northern blot analysis (Fig. 5, C and
D) revealed NCX2 transcripts, which were present in cells
cultured in 5.3 mM KCl. In agreement with the observations
at the protein level, FK506 and cyclosporin A partially prevented the
down-regulation of the NCX2 transcripts introduced by the depolarizing
treatment, whereas rapamycin had no effect unless present in a
2000-fold excess over FK506 (Fig. 5C). In contrast to NCX2,
the immunosupressants failed to affect the depolarization-mediated
expression of the NCX1 splice variants and the up-regulation of the
NCX3 transcripts (results not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 5.
Depolarization mediated,
calcineurin-dependent down-regulation of NCX2.
A, expression of NCX2. Cells were cultured under
depolarizing (25 mM KCl) or physiological (5.3 mM KCl) conditions for 5 days in the presence of 1 nM FK506 (FK), 100 nM cyclosporin A
(CsA), 2 µM rapamycin (Rap), or 1 nM FK506 plus 2 µM rapamycin
(F+R). 20 µg of crude membrane proteins from granule cells
were separated by SDS-PAGE (8%) and transferred to nitrocellulose
sheets. Western blotting was carried out with affinity-purified
polyclonal antibodies against NCX2 (upper panel) and the
IP3 receptor isoform 1 (lower panel).
B, immunoprecipitation of NCX2 from granule cells. Cells
were cultured in the presence of 5.3 mM KCl, 25 mM KCl, or 25 mM KCl and 100 nM
FK506. After 4 days, cells were labeled overnight with
[35S]methionine (150 µCi/ml), and crude membrane
proteins were prepared. Aliquots corresponding to 5 × 106 cpm were immunoprecipitated with the anti-NCX2
polyclonal antiserum. The immunocomplexes were recovered with protein
A-Sepharose. The dried SDS-PAGE gel was exposed to a PhosphorImager
plate. The sizes of the molecular markers are given to the
left of the panel. C and D,
calcineurin effects on NCX2 transcripts. C, RT-PCR analysis
of NCX2 expression in granule cells in the presence of
immunosuppressants. Cells were treated as described in panel
A. 1.5-2 µg of total cell RNA was reverse transcribed and
amplified by NCX2-specific primers. PCR products were separated on 8%
PAGE and visualized by ethidium bromide staining. D,
Northern blotting analysis of NCX2 transcripts in granule cells. Cells
were grown under depolarizing conditions for 5 days with 1 nM FK506 or 100 nM cyclosporin A
(CsA). 20 µg of total RNA were subjected to Northern
blotting. Random primer-amplified NCX2 or G3PDH-specific DNA fragments
were used as probes.
|
|
The large changes in NCX2 protein and transcripts could not be used to
evaluate quantitatively the contribution of NCX2 to the total exchanger
activity of granule cells. To address this important question, the
activity of the exchanger was measured in cells cultured for 7 days in
the presence of 25 mM KCl and in the presence or absence of
FK506. Cells cultured in 100 nM FK506 had 30-40% more
exchanger activity than cells grown under the same conditions but in
the absence of the immunosuppressant (Fig.
6). Attempts were made also to measure
the activity of the exchanger in cells cultured in 5.3 mM
KCl. Unfortunately, they were unsuccessful because the few cells
remaining after 5-7 days were very fragile and did not survive the
washes required to measure exchanger activity. Thus, at the end of the
maturation process one-third of the exchanger activity of granule cells
was evidently due to NCX2.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
NCX activity of granule cells. Cells
were grown in medium containing 25 mM KCl or 25 mM KCl + 100 nM FK506 for 7 days and used for
the 45Ca2+ uptake experiments (see
"Experimental Procedures" for details). Cells were preloaded with
140 mM NaCl, and Ca2+ uptake was initiated by
adding 45Ca2+ to a 140 mM KCl
medium (gray bars). Controls were performed by adding
45Ca2+ to cells diluted in 140 mM
NaCl (open bars) The values were the average ± S.E. of
three experiments on three different cell batches.
|
|
The experiments presented above have shown that calcineurin plays a
role in the down-regulation of NCX2. When the phosphatase was inactive,
i.e. high KCl plus FK506 or low KCl, a strong up-regulation of the expression of NCX2 was observed instead (Fig.
7, compare Figs. 2C and
3C). The increase in NCX2 protein in cells cultured in low
KCl was equivalent to that observed in 25 mM KCl and 100 nM FK506 (Fig. 7), indicating that calcineurin was
insufficiently active in the low Ca2+ medium prevailing
within cells cultured in low KCl. Alternatively, factors that
counteracted the presumably limited activity of calcineurin in granule
neurons cultured in 5.3 mM KCl could have permitted the
up-regulation of the expression of NCX2.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 7.
The expression of NCX2 increases with the
maturation of granule cells and is inhibited by calcineurin.
Granule cells were cultured under non-depolarizing (5.3 mM
KCl) or depolarizing (25 mM KCl) conditions for 2, 3, 5, and 7 days in the presence or absence of 100 nM FK506. 20 µg of crude membrane proteins were separated on SDS-PAGE (8%) and
subjected to Western blotting with the affinity-purified NCX2
antibodies. The positions of the NCX2 bands are indicated by the
arrows. The same material was analyzed with the NCX1
specific antibody, showing no changes in the concentration of NCX1 (not
shown).
|
|
Calcium Regulation of NCX2 Expression Is Fast and Does Not Require
de Novo Protein Synthesis--
Kinetics studies were performed next on
the expression of NCX2 in granule cells initially cultured for 3 days
in 5.3 mM KCl and then submitted to different treatments
(Fig. 8). These studies showed that the
down-regulation of the transcript was fast; at 1 h after the
addition of 25 mM KCl, the NCX2 signal had already disappeared (Fig. 8). The decrease of the transcript was as fast as the
up-regulation of that of the immediate early gene c-fos, which was used as a control (Fig. 8). Inhibition of protein translation by cycloheximide failed to affect the change in NCX2 transcript, showing that its down-regulation did not require de novo
protein synthesis. This finding was in sharp contrast to the transcript of PMCA4CII (plasma membrane Ca2+-ATPase isoform 4), which
was also found to be down-regulated in granule cells upon
depolarization (48). The PMCA4CII transcripts disappeared more slowly
than the NCX2 transcripts; in the case of the PMCA, the disappearance
was prevented by cycloheximide (Fig. 8).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 8.
RT-PCR analysis of the kinetics of NCX2
down-regulation. Granule cells were cultured for 3 days in 5.3 mM KCl and then divided into two portions. One portion was
kept in 5.3 mM KCl, and cells were collected after 0, 6, and 12 h. The other was depolarized with 25 mM KCl for
15 min, 60 min, 6 h, or 12 h in the presence or absence of 10 µg/ml cycloheximide (CHX). The treatment with
cycloheximide lasted 10 min, and then depolarization was initiated.
After the cells were collected, total RNA was prepared and an aliquot
was subjected to RT-PCR with NCX2-, c-fos-, or
PMCA4CII-specific primers (see details under "Experimental
Procedures"). A typical experiment is shown, which was repeated three
times with the same results.
|
|
 |
DISCUSSION |
Numerous NCX isoforms are expressed in different tissues. It is
possible that 12 NCX1, 1 NCX2, and 4 NCX3
variants are generated by alternative splicing of the primary
transcripts (47). In addition, the use of three independent promoters
produces three NCX1 transcripts differing in the 5'-untranslated
sequence (22, 23, 47, 49). The expression of the isoforms appears to be regulated by independent mechanisms; understanding them would be
important and would help in rationalizing both the regulation mechanisms and the changes in isoform composition during development.
Western blot analysis showed that the NCX2 protein increased during the
early development of the cerebellum. Following this finding, the work
then concentrated on the expression of the NCX genes in granule cells,
which undergo very significant morphological changes during the first
days in culture. Mild depolarizing conditions (25 mM KCl)
amplify these phenotypic changes and, most importantly, prevent the
onset of early apoptosis. At plating time, rat granule cells contained
all three basic NCX isoforms. Seven spliced variants of the transcripts
were detected in the case of NCX1; The depolarizing treatment
influenced their expression pattern, although the total amount of
expressed NCX1 protein did not change appreciably during this time.
Depolarization also up-regulated the NCX3 transcripts, but the most
striking behavior was in the NCX2 isoform. Whereas under physiological
(non-depolarizing) conditions its expression (transcripts and protein)
showed an evident time-dependent increase (10-20-fold as
protein), the isoform decreased dramatically instead in cells cultured
under conditions (depolarization) that promoted the influx of
Ca2+. An important corollary of the down-regulation of NCX2
was its complete dependence on calcineurin, which had no effect on the expression of the other two NCX isoforms. The experiments strongly suggest a transcriptional effect of calcineurin, even if it could be
argued that they have not rigorously demonstrated it; the phosphatase could have influenced instead the processing of the transcript to
mature mRNA or affected the stability of the latter. However, the
complete disappearance of the NCX2 transcript soon after initiating the
depolarization appears more in line with a promoter effect. The rapid
kinetics of NCX2 down-regulation and its independence on de
novo protein synthesis suggest a direct phosphatase-mediated modulation of the activity of the nuclear protein complex controlling the transcription of the NCX2 gene.
Calcineurin is now attracting wide attention as a regulator of gene
transcription. Its action has been characterized in T-lymphocytes (50),
whose activation is linked to the entry of Ca2+, resulting
in the stimulation of the phosphatase and in the dephosphorylation of
the transcription factor NFAT. The factor then translocates to the
nucleus together with calcineurin, where it up-regulates the
transcription of a set of T-cell-specific genes (50). The finding is
not limited to T-cells; evidence for the presence of a variant of NFAT
(NFAT-3c) in hippocampal cells has been recently published (51). Also
in this case calcineurin controlled its dephosphorylation and
translocation to the nucleus. A similar situation also prevails in
Saccharomyces cerevisiae, where the transcription factor
Crz1p is dephosphorylated by calcineurin and then translocated to the
nucleus (52). In an alternative mode of action, calcineurin promotes
the activation of protein phosphatase-1, leading to the
dephosphorylation of the transcription factor CREB (cAMP response
element-binding protein) (50), which controls the expression of
immediate early genes like c-fos (53). Although the
activation of protein phosphatase-1 could still play a role in granule
cells, the effect of calcineurin on the expression of NCX2 was more
reminiscent of that observed in T-cells in hippocampal neurons and
Saccharomyces. The very rapid onset of NCX2 down-regulation (only 1 h after initiating the depolarizing treatment) and the finding that de novo protein synthesis was not required
strongly suggest that the calcineurin effect was mediated by the
dephosphorylation of a (pre-existing) transcription factor. Possibly,
analogously with T-cells, hippocampal neurons, and yeast, this would
permit the transfer of this putative factor to the nucleus.
The functional tests performed in this study have shown that the
activity of NCX2 in granule neurons was high, i.e. it
accounted for up to 30-40% of the total exchanger activity. Granule
cells also contain the NCX1 and NCX3 isoforms. The multiplicity of
isoforms in brain is not easily rationalized, the chief difficulty
being the very scarce information on their differential functional
properties (e.g. their regulation characteristics). Despite
this difficulty, however, granule cells evidently have the option of
modifying their total exchanger activity in response to the increase in intracellular Ca2+. Even if no information is available on
the differential functional properties of the three exchanger types,
the results clearly support the suggestion that the NCX2 exchanger is
functionally different from the other isoforms. The (moderate)
up-regulation of NCX3 expression and the reshuffling of the splice
variants of NCX1 are not likely to compensate for the down-regulation
of NCX2 occurring under these conditions. In contrast, neurons cultured
under conditions that did not lead to the sustained increase of
intracellular Ca2+ (and to the activation of calcineurin)
strongly up-regulated NCX2. Evidently, Ca2+ acts as a
switch that can reverse the expression of NCX2 when conditions prevail
that lead to the increase of Ca2+ in the cell. This
discussion must, for the moment, be restricted to the total
quantitative aspects of NCX activity; but the NCX2-NCX1-NCX3 shift is
also likely to have qualitative consequences, the full assessment of
which will be possible only in the future.
The conditions that led to the down-regulation of NCX2 are those that
promoted the long term survival of cultured granule cells. In the
developing cerebellum, granule cells survive instead under conditions
that promote the up-regulation of NCX2. This finding may indicate that
these cells in the cerebellum avoid apoptosis by mechanisms unrelated
to membrane depolarization (unless the up-regulation of NCX2 in the
tissue also reflected the contribution of other cell types). It would
be important to understand why Ca2+, which is not strictly
necessary for maturation, is instead essential to protect granule cells
against (apoptotic) death. Clues to this question have come from recent
work on the activation of the protein kinase B pathway (54), which is
controlled by the calmodulin-dependent kinase-kinase
(CaMKK). A modest increase of cell Ca2+ activates CaMKK,
and leads to the phosphorylation of protein kinase B. In turn,
activated protein kinase B phosphorylates the pre-apoptotic protein
BAD, leading to its sequestration to protein 14-3-3. The important
point is that the increase of cell Ca2+ to activate CaMKK
must be modest, precisely as observed in granule neurons depolarized by
25 mM KCl; a massive, uncontrolled Ca2+
overload would evidently be incompatible with cell survival. Thus, one
could relate the changes in NCX isoform pattern induced by the
depolarizing treatment to the necessity of maintaining the
Ca2+ increase within the limits required to switch off the
apoptotic signals, effectively preventing its uncontrolled increase to
intolerable levels.
In cultured granule neurons, the large amounts of Ca2+ that
penetrate through the plasma membrane channels are eventually extruded by Ca2+-ATPases and Na+/Ca2+
exchangers. Recent work has shown that two isoforms of the former, present in low amounts at plating time, became slowly (i.e.
3-5 days) up-regulated during the depolarizing treatment, whereas a
third experienced a switch of its spliced variants up-regulating a less
active truncated form (45). In analogy with the findings on NCX, one
PMCA isoform underwent instead a rapid,
Ca2+-calcineurin-mediated down-regulation. One could thus
envisage a situation in which, at early stages of in vitro
development, the contribution of the exchanger(s) to the total
Ca2+ extrusion from granule cells predominates, because
relatively small amounts of the PMCA pumps are present. However, after
maturation has occurred in a few days, the contribution of the strongly
up-regulated pumps is likely to become predominant. Because the
depolarizing treatment eventually increases the total pump activity
(45), it would be reasonable to expect that at this stage cells would have a lower cytosolic Ca2+ concentration. The fact that
the opposite was found to be true was probably because of the
compensation of the increased pump activity by the down-regulation of
the NCX2 exchanger. Thus, granule cells apparently react to the
persistent increase of Ca2+ influx not only by changing the
pattern of NCX expression but also by changing that of other
Ca2+ extruding systems, i.e. they switch from
exchangers to pumps. Future work will possibly detect (subtle)
functional differences among the variants of the pumps and the
exchangers, leading to a better understanding of the physiological
implications of the findings described here.
However, other points are probably also important in discussing the
results in this study, in primis possible differences in the
subcellular localization of the NCX (and PMCA) proteins. Some plasma
membrane proteins, in particular in neurons, have a very defined
subcellular localization, which is controlled by specific proteins. For
instance, the synaptic localization of the NMDA
(N-methyl-D-aspartate) receptor is mediated by the PSD-95 protein (55). It is therefore possible that one of the NCX isoforms is
localized predominantly in a selected region of the neuronal plasma
membrane, e.g. in the synapse. The enrichment or decrease of
the exchanger proteins in particular domains of the plasma membrane
would naturally significantly affect local Ca2+ swings. The
same would apply to the PMCA pumps, where evidence for their
dishomogeneous distribution along the plasma membrane has actually been
provided; the PMCA2 pump is specifically concentrated in the spines of
the dendrites of Purkinje neurons (56).
In closing, it may be appropriate to mention again that the
up-regulation of the inositol 1,4,5-trisphosphate receptor (44) and the
down-regulation of one of the PMCA isoforms in granule cells are also
dependent on calcineurin. Calcineurin is thus crucial to the expression
of Ca2+ transporters during the development of granule
neurons and emerges as a key actor in the expression of genes involved
in (Ca2+-linked) neuronal signal transduction. It might
even emerge as a major player in the expression of genes underlying
cognitive processes in the brain.
 |
ACKNOWLEDGEMENTS |
We thank Dr. B. Moss (National Institutes of
Health, Bethesda, MD) for the kind gift of the recombinant virus and
the pTM3 vector.
 |
FOOTNOTES |
*
This work was made possible by the support of the Swiss
National Science foundation, the Italian Ministry of University and Scientific Research (MURST-PRIN 1998), the National Research Council of
Italy (Target Project on Biotechnology), and the Armenise-Harvard Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
0039-049-8276137; Fax: 0039-049-8276125; E-mail:
carafoli@civ.bio.unipd.it.
Published, JBC Papers in Press, April 14, 2000, DOI 10.1074/jbc.M000995200
 |
ABBREVIATIONS |
The abbreviations used are:
NCX1, NCX2, NCX3,
exchanger types 1, 2, 3, cDNA;
RT, reverse transcriptase;
PCR, polymerase chain reaction;
PAGE, polyacrylamide gel electrophoresis;
CaMKK, calmodulin-dependent kinase-kinase;
G3PDH, glyceraldehyde-3-phosphate dehydrogenase;
PMCA, plasma membrane
Ca2+ pump.
 |
REFERENCES |
| 1.
|
Carafoli, E.
(1994)
FASEB J.
8,
993-1002
|
| 2.
|
Philipson, K. D.,
and Nicoll, D. A.
(1992)
Curr. Opin. Cell Biol.
4,
678-683
|
| 3.
|
Nicoll, D. A.,
Longoni, S.,
and Philipson, K. D.
(1990)
Science
250,
562-565
|
| 4.
|
Aceto, J. F.,
Condrescu, M.,
Kroupis, C.,
Nelson, H.,
Nelson, N.,
Nicoll, D.,
Philipson, K. D.,
and Reeves, J. P.
(1992)
Arch. Biochem. Biophys.
298,
553-560
|
| 5.
|
Komuro, I.,
Wenninger, K. E.,
Philipson, K. D.,
and Izumo, S.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4769-4773
|
| 6.
|
Low, W.,
Kasir, J.,
and Rahamimoff, H.
(1993)
FEBS Lett.
316,
63-67
|
| 7.
|
Tsuruya, Y.,
Bersohn, M. M.,
Li, Z.,
Nicoll, D. A.,
and Philipson, K. D.
(1994)
Biochim. Biophys. Acta
1196,
97-99
|
| 8.
|
Kim, I.,
and Lee, C. O.
(1996)
Ann. N. Y. Acad. Sci.
779,
126-128
|
| 9.
|
Iwata, T.,
Kraev, A.,
Guerini, D.,
and Carafoli, E.
(1996)
Ann. N. Y. Acad. Sci.
779,
37-45
|
| 10.
|
Ruknudin, A.,
Valdivia, C.,
Kofuji, P.,
Lederer, W. J.,
and Schulze, D. H.
(1997)
Am. J. Physiol.
273,
C257-C265
|
| 11.
|
Schwarzer, A.,
Kim, T. S. Y.,
Hagen, V.,
Molday, R. S.,
and Bauer, P. J.
(1997)
Biochemistry
36,
13667-13676
|
| 12.
|
Hryshko, L. V.,
Nicoll, D. A.,
Weiss, J. N.,
and Philipson, K. D.
(1993)
Biochim. Biophys. Acta
1151,
35-42
|
| 13.
|
Furman, I.,
Cook, O.,
Kasir, J.,
Low, W.,
and Rahamimoff, H.
(1995)
J. Biol. Chem.
270,
19120-19127
|
| 14.
|
Loo, T. W.,
Ho, C.,
and Clarke, D. M.
(1995)
J. Biol. Chem.
270,
19345-19350
|
| 15.
|
Sahin Toth, M.,
Nicoll, D. A.,
Frank, J. S.,
Philipson, K. D.,
and Friedlander, M.
(1995)
Biochem. Biophys. Res. Commun.
212,
968-974
|
| 16.
|
Nicoll, D. A.,
Ottolia, M.,
Lu, L.,
Lu, Y.,
and Philipson, K. D.
(1999)
J. Biol. Chem.
274,
910-917
|
| 17.
|
Levitsky, D. O.,
Nicoll, D. A.,
and Philipson, K. D.
(1994)
J. Biol. Chem.
269,
22847-22852
|
| 18.
|
Matsuoka, S.,
Nicoll, D. A.,
Hryshko, L. V.,
Levitsky, D. O.,
Weiss, J. N.,
and Philipson, K. D.
(1995)
J. Gen. Physiol.
105,
403-420
|
| 19.
|
Matsuoka, S.,
Nicoll, D. A.,
Reilly, R. F.,
Hilgemann, D. W.,
and Philipson, K. D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3870-3874
|
| 20.
|
Kofuji, P.,
Lederer, W. J.,
and Schulze, D. H.
(1994)
J. Biol. Chem.
269,
5145-5149
|
| 21.
|
Lee, S. L., Yu, A. S.,
and Lytton, J.
(1994)
J. Biol. Chem.
269,
14849-14852
|
| 22.
|
Barnes, K. V.,
Cheng, G.,
Dawson, M. M.,
and Menick, D. R.
(1997)
J. Biol. Chem.
272,
11510-11517
|
| 23.
|
Scheller, T.,
Kraev, A.,
Skinner, S.,
and Carafoli, E.
(1998)
J. Biol. Chem.
273,
7643-7649
|
| 24.
|
He, S.,
Ruknudin, A.,
Bambrick, L. L.,
Lederer, W. J.,
and Schulze, D. H.
(1998)
J. Neurosci.
18,
4833-4841
|
| 25.
|
Menick, D. R.,
Barnes, K. V.,
Dawson, M. M.,
Kent, R. L.,
and Cooper, G. T.
(1996)
J.
Cardiovasc. Fail.
2 Suppl. 4,
S69-S76
|
| 26.
|
Smith, L.,
and Smith, J. B.
(1994)
J. Biol. Chem.
269,
27527-27531
|
| 27.
|
Smith, L.,
Porzig, H.,
Lee, H. W.,
and Smith, J. B.
(1995)
Am. J. Physiol.
269,
C457-C463
|
| 28.
|
Boerth, S.,
Zimmer, D.,
and Artman, M.
(1994)
Circ. Res.
74,
354-359
|
| 29.
|
Kent, R.,
Rozich, J.,
McCollam, P.,
McDermott, D.,
Thacker, U.,
Menick, D.,
McDermott, P.,
and Cooper, G. t.
(1993)
Am. J. Physiol.
265,
H1024-H1029
|
| 30.
|
Li, Z.,
Matsuoka, S.,
Hryshko, L. V.,
Nicoll, D. A.,
Bersohn, M. M.,
Burke, E. P.,
Lipton, R. P.,
and Philipson, K. D.
(1994)
J. Biol. Chem.
269,
17434-17439
|
| 31.
|
Nicoll, D. A.,
Quednau, B. D.,
Qui, Z.,
Xia, Y. R.,
Lusis, A. J.,
and Philipson, K. D.
(1996)
J. Biol. Chem.
271,
24914-24921
|
| 32.
|
Linck, B.,
Qiu, Z.,
He, Z.,
Tong, Q.,
Hilgemann, D. W.,
and Philipson, K. D.
(1998)
Am. J. Physiol.
274,
C415-C423
|
| 33.
|
Iwata, T.,
Galli, C.,
Dainese, P.,
Guerini, D.,
and Carafoli, E.
(1995)
Cell Calcium
17,
263-269
|
| 34.
|
Gallo, V.,
Kingsbury, A.,
Balázs, R.,
and Jørgensen, O. S.
(1987)
J. Neurosci.
7,
2203-2213
|
| 35.
|
Carmichael, J.,
DeGraff, W. G.,
Gazdar, A. F.,
Minna, J. D.,
and Mitchell, J. B.
(1987)
Cancer Res.
47,
943-946
|
| 36.
|
Foletti, D.,
Guerini, D.,
and Carafoli, E.
(1995)
FASEB J.
9,
670-680
|
| 37.
|
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159
|
| 38.
|
Tso, J. Y.,
Sun, X. H.,
Kao, T. H.,
Reece, K. S.,
and Wu, R.
(1985)
Nucleic Acids Res.
13,
2485-2502
|
| 39.
|
Towbin, H.,
Staehlin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
|
| 40.
|
Stauffer, T.,
Guerini, D.,
and Carafoli, E.
(1995)
J. Biol. Chem.
270,
12184-12190
|
| 41.
|
Santacruz-Tolosa, L.,
Ottolia, M.,
Nicoll, D. A.,
and Philipson, K. D.
(1999)
J. Biol. Chem.
275,
182-188
|
| 42.
|
Guerini, D.,
Garcia Martin, E.,
Zecca, A.,
Guidi, F.,
and Carafoli, E.
(1998)
Acta Physiol. Scand. Suppl.
643,
265-273
|
| 43.
|
Bessho, Y.,
Nawa, H.,
and Nakanishi, S.
(1994)
Neuron
12,
87-95
|
| 44.
|
Genazzani, A. A.,
Carafoli, E.,
and Guerini, D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5797-5801
|
| 45.
|
Guerini, D.,
Garcia Martin, E.,
Gerber, A.,
Volbracht, C.,
Leist, M.,
Merino, C. G.,
and Carafoli, E.
(1999)
J. Biol. Chem.
274,
1667-1676
|
| 46.
|
Carafoli, E.,
Genazzani, A.,
and Guerini, D.
(1999)
Biochem. Biophys. Res. Commun.
266,
624-623
|
| 47.
|
Quednau, B. D.,
Nicoll, D. A.,
and Philipson, K. D.
(1997)
Am. J. Physiol.
272,
C1250-C1261
|
| 48.
|
Guerini, D.,
Wang, X.,
Li, L.,
Genazzani, A.,
and Carafoli, E.
(2000)
J. Biol. Chem.
275,
3706-3712
|
| 49.
|
Nicholas, S. B.,
Yang, W.,
Lee, S. L.,
Zhu, H.,
Philipson, K. D.,
and Lytton, J.
(1998)
Am. J. Physiol.
274,
H217-H232
|
| 50.
|
Klee, C. B.,
Ren, H.,
and Wang, X.
(1998)
J. Biol. Chem.
273,
13367-13370
|
| 51.
|
Graef, I. A.,
Mermelstein, P. G.,
Stankunas, K.,
Neilson, J. R.,
Deisseroth, K.,
Tsien,
and Crabtree, R. G.
(1999)
Nature
401,
703-708
|
| 52.
|
Stathopoulos-Gerontides, A.,
Jun Guo, J.,
and Cyert, M. S.
(1999)
Genes Dev.
13,
798-803
|
| 53.
|
Bito, H.,
Deisseroth, K.,
and Tsien, R. W.
(1996)
Cell
87,
1203-1214
|
| 54.
|
Yano, S.,
Tokumitsu, H.,
and Soderling, T. R.
(1998)
Nature
396,
584-587
|
| 55.
|
O'Brien, R. J.,
Lau, L. F.,
and Huganir, R. L.
(1998)
Curr. Opin. Neurobiol.
8,
364-369
|
| 56.
|
Stauffer, T. P.,
Guerini, D.,
Celio, M. R.,
and Carafoli, E.
(1997)
Brain Res.
748,
21-29
|
| 57.
|
Soldati, L.,
Longoni, S.,
and Carafoli, E.
(1985)
J. Biol. Chem.
260,
13321-11332
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Smith, A. E. Chappell, A. G. Buret, K. E. Barrett, and H. Dong
5-Hydroxytryptamine contributes significantly to a reflex pathway by which the duodenal mucosa protects itself from gastric acid injury
FASEB J,
December 1, 2006;
20(14):
2486 - 2495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dong, Y. Jiang, C. R. Triggle, X. Li, and J. Lytton
Novel role for K+-dependent Na+/Ca2+ exchangers in regulation of cytoplasmic free Ca2+ and contractility in arterial smooth muscle
Am J Physiol Heart Circ Physiol,
September 1, 2006;
291(3):
H1226 - H1235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Pulina, R. Rizzuto, M. Brini, and E. Carafoli
Inhibitory Interaction of the Plasma Membrane Na+/Ca2+ Exchangers with the 14-3-3 Proteins
J. Biol. Chem.,
July 14, 2006;
281(28):
19645 - 19654.
[Abstract]
[Full Text]
|